Myeloma drugs for 2018 - Anti-body drug conjugates, Bi-specific T-cell engagers, etc. - 101931

Spotlight
Video

Myeloma drugs for 2018 - Anti-body drug conjugates, Bi-specific T-cell engagers, etc.

ASHReport has 270 videos Subscribe Here

Loading........
Description: Robert Z. Orlowski, MD, PhD, from MD Anderson Cancer Center discusses myeloma drugs for 2018 and anti-body drug conjugates, Bi-specific T-cell engagers, etc. at the 2017 American Society of Hematology.

Shared By : ASHReport
Posted on : 01/15/18
Added : 11 months ago
Category : Multiple Myeloma